United States · FDA National Drug Code directory
Testopel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66887-004_0a13cf12-e51e-4d3d-a7c4-ea74712e6db2
- Product NDC
- 66887-004
- Form
- PELLET
- Composition / generic term
- testosterone
- Labeler
- Endo USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141031
- Source listing expiry
- 20261231
Source-listed ingredients
- TESTOSTERONE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 AMPULE in 1 BOX (66887-004-10) / 1 PELLET in 1 AMPULE (66887-004-01) · 66887-004-10
- 100 AMPULE in 1 BOX (66887-004-20) / 1 PELLET in 1 AMPULE (66887-004-01) · 66887-004-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →